Form 4: Xtant Medical Holdings Executive Kevin Brandt Reports Acquisition and Disposal of Shares

Chief Commercial Officer Kevin Brandt reports acquiring shares through a restricted stock unit award and disposing of shares, resulting in a total beneficial ownership of 1,000,069 shares.

Summary

• Kevin D. Brandt, Chief Commercial Officer of Xtant Medical Holdings, Inc., filed a Form 4.
• The report details transactions involving Xtant Medical Holdings, Inc. common stock.
• On April 3, 2024, Brandt acquired 184,209 shares of common stock through a restricted stock unit award.
• The acquisition price was $0.
• Also on April 3, 2024, Brandt disposed of shares.
• Following these transactions, Brandt beneficially owns 1,000,069 shares of Xtant Medical Holdings, Inc.
• The acquired shares will vest over four years, starting April 3, 2025, conditioned upon Brandt's continued employment.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The acquisition of shares through vesting RSUs is a positive sign, but the disposal of shares offsets this to some extent.

Positives

• The acquisition of shares through restricted stock units aligns the executive's interests with the company's long-term performance.
• The vesting schedule encourages continued employment and commitment to Xtant Medical Holdings, Inc.

Risks

• The vesting of the acquired shares is contingent upon Brandt's continued employment, creating a potential risk if he were to leave the company before the vesting dates.

Future Outlook

The executive's continued holding of a significant number of shares suggests confidence in the company's future prospects.

Industry Context

Executive stock transactions are common in the medical device industry and are often used to align management's interests with those of shareholders.

Stakeholder Impact

• The reported transactions may influence investor sentiment regarding the company's prospects.
• The vesting of restricted stock units incentivizes the executive to remain with the company, benefiting employees and shareholders.

Key Dates